First Time Loading...

ContextVision AB
OSE:CONTX

Watchlist Manager
ContextVision AB Logo
ContextVision AB
OSE:CONTX
Watchlist
Price: 5.9 NOK -1.67% Market Closed
Updated: May 14, 2024
Section:
 

Relative Value

The Relative Value of one CONTX stock under the Base Case scenario is 10.1 NOK. Compared to the current market price of 5.9 NOK, ContextVision AB is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CONTX Relative Value
Base Case
10.1 NOK
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
96
vs Industry
35
Median 3Y
6.2
Median 5Y
7
Industry
2.4
Forward
3.4
More Details
14
P/E
P/E
Price to Earnings
14
vs History
73
vs Industry
36
Median 3Y
15.8
Median 5Y
22.9
Industry
23.9
Forward
19.3
More Details
10.2
P/OCF
P/OCF
Price to OCF
10.2
vs History
96
vs Industry
35
Median 3Y
29.3
Median 5Y
43.3
Industry
15.6
More Details
11.6
P/FCFE
P/FCFE
Price to FCFE
11.6
vs History
73
vs Industry
32
Median 3Y
40.5
Median 5Y
40.5
Industry
22.5
More Details
5.9
P/B
P/B
Price to Book Value
5.9
vs History
96
vs Industry
13
Median 3Y
12.6
Median 5Y
12.6
Industry
2.3
More Details
3.1
EV/S
EV/S
Enterprise Value to Sales
3.1
vs History
96
vs Industry
37
Median 3Y
6
Median 5Y
6.7
Industry
2.5
Forward
2.9
More Details
3.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.1
vs History
96
vs Industry
59
Median 3Y
5.9
Median 5Y
6.9
Industry
5.3
More Details
8.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.3
vs History
96
vs Industry
38
Median 3Y
12.9
Median 5Y
19.8
Industry
12.9
Forward
8
More Details
10.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.1
vs History
96
vs Industry
39
Median 3Y
15.7
Median 5Y
24.7
Industry
17.8
Forward
13.6
More Details
9.1
EV/OCF
EV/OCF
Enterprise Value to OCF
9.1
vs History
96
vs Industry
40
Median 3Y
27.8
Median 5Y
41.2
Industry
15.4
More Details
9.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.2
vs History
82
vs Industry
36
Median 3Y
39.5
Median 5Y
72.3
Industry
19.6
More Details
9
EV/IC
EV/IC
Enterprise Value to IC
9
vs History
95
vs Industry
9
Median 3Y
13.1
Median 5Y
13.1
Industry
2
More Details

Multiples Across Competitors

CONTX Competitors Multiples
ContextVision AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
ContextVision AB
OSE:CONTX
461.1m NOK 3.5 14 8.3 10.1
US
Veeva Systems Inc
NYSE:VEEV
32.9B USD 13.9 62.5 62.5 67.2
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.8B AUD 81 169.8 116.8 116.8
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.9 12.4 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
4.8B USD 7.3 -306.7 -133.2 -121.8
US
Doximity Inc
NYSE:DOCS
4.3B USD 9.2 31.4 20.8 22.2
SE
Sectra AB
STO:SECT B
45.2B SEK 27.6 106.5 -70.1 -70.1
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
US
Evolent Health Inc
NYSE:EVH
2.7B USD 1.4 -19.3 23.1 245.7
P/E Multiple
Earnings Growth
SE
ContextVision AB
OSE:CONTX
Average P/E: 65
14
5%
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
169.8
119%
JP
M3 Inc
TSE:2413
23.9
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -306.7 N/A
US
Doximity Inc
NYSE:DOCS
31.4
79%
SE
Sectra AB
STO:SECT B
106.5
56%
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.3 N/A
EV/EBITDA Multiple
EBITDA Growth
SE
ContextVision AB
OSE:CONTX
Average EV/EBITDA: 60.5
8.3
23%
US
Veeva Systems Inc
NYSE:VEEV
62.5
211%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
116.8
124%
JP
M3 Inc
TSE:2413
12.4
24%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -133.2 N/A
US
Doximity Inc
NYSE:DOCS
20.8
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.1 N/A
US
Vocera Communications Inc
NYSE:VCRA
264.4
N/A
US
Evolent Health Inc
NYSE:EVH
23.1
194%
EV/EBIT Multiple
EBIT Growth
SE
ContextVision AB
OSE:CONTX
Average EV/EBIT: 539.9
10.1
8%
US
Veeva Systems Inc
NYSE:VEEV
67.2
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
116.8
110%
JP
M3 Inc
TSE:2413
13.9
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -121.8 N/A
US
Doximity Inc
NYSE:DOCS
22.2
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.1 N/A
US
Vocera Communications Inc
NYSE:VCRA
4 233.4
N/A
US
Evolent Health Inc
NYSE:EVH
245.7
2 086%

See Also

Summary
CONTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CONTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CONTX stock valuation using valuation multiples.
Wall Street Estimates
CONTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CONTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.